A Phase 3, Interventional, Randomized, Multicenter, Open-Label Study of DCC-2618 vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumors after Treatment with Imatinib.

  • Zalcberg, John (Primary Chief Investigator (PCI))
  • Cross, Nikki (Project Manager)

Project: Research

StatusActive
Effective start/end date9/05/1931/12/24

Keywords

  • Medical Oncology
  • Gastrointestinal stromal tumors
  • Clinical trial
  • Medical Oncology
  • Gastrointestinal stromal tumors
  • Clinical trial
  • Medical Oncology
  • Gastrointestinal stromal tumors
  • Clinical trial